Check out

Tuesday, September 23, 2025

F.D.A.’s Approval of Drug for Autism Upends Review Process

The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.

from NYT > Health https://ift.tt/8TuzYK1

No comments:

Post a Comment

A Newer Kind of Gene Editing Promises to Edit ‘Nurture’ Over ‘Nature’

Traditional gene editing rewrites DNA. But a new approach, called epigenome editing, aims to treat the molecular scars we collect throughout...